Brief: LianBio Completes Enrollment In Phase 3 Trial Of TP-03

LianBio

08/06/2023 14:35

June 8 (Reuters) - LianBio  LIAN.O :
    * LIANBIO COMPLETES ENROLLMENT IN PIVOTAL PHASE 3 LIBRA
TRIAL OF
TP-03 IN CHINESE PATIENTS WITH DEMODEX BLEPHARITIS
    * LIANBIO - TOPLINE RESULTS EXPECTED IN Q4 OF 2023

Source text for Eikon:  ID:nGNX92lsYP 
Further company coverage:  LIAN.O 

 (Reuters.briefs@thomsonreuters.com)